Growth through acquisition InVita recently acquired IT Synergistics, signaling an expansion of capabilities and client footprint. This presents an opportunity to cross-sell integrated solutions, leverage combined install bases, and position enhanced offerings to existing customers and new prospects seeking broader workflow automation in regulated health sectors.

Strategic partnerships Recent collaborations with Gulf Coast Blood and Giveblood to introduce advanced therapy capabilities indicate a market push into blood centers and transplantation networks. Use these partnerships to approach other blood centers, donation organizations, and OPOs with joint value propositions around HemaConnect enhancements and therapy-capable workflows.

Regulated industry focus InVita specializes in regulated environments (donation-transplant, blood management, forensic labs) with compliance safeguards and ISO/IEC 27001 alignment. This creates a sales angle for highly regulated healthcare customers seeking proven governance, auditability, and data security across procurement cycles and RFPs.

Product leadership With multiple product lines (Implant & Explant lifecycle, Blood & Plasma management, DNA & Forensic sample management, Donation-Transplant management) and recent product releases like iTransplant and iReferral, there are upsell opportunities to expand to current users and target institutions implementing end-to-end life-cycle solutions and referral automation.

Public health impact Customers include hospitals, health systems, organ/tissue donation networks, and forensic labs, all aiming to improve patient safety and operational efficiency. Target opportunities include scale-ups in community blood centers, organ procurement organizations, and state/regional health networks seeking interoperable, compliant software to improve throughput and outcomes.